Tiziana Pivetta Selected Research

Copper

12/2021	Copper(II) Phenanthroline-Based Complexes as Potential AntiCancer Drugs: A Walkthrough on the Mechanisms of Action.
1/2019	Mixed copper(ii)-phenanthroline complexes induce cell death of ovarian cancer cells by evoking the unfolded protein response.
3/2011	Synthesis, structural characterization, formation constants and in vitro cytotoxicity of phenanthroline and imidazolidine-2-thione copper(II) complexes.
4/2008	Potentiometric, spectrophotometric and calorimetric study on iron(III) and copper(II) complexes with 1,2-dimethyl-3-hydroxy-4-pyridinone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tiziana Pivetta Research Topics

Disease

7	Neoplasms (Cancer) 12/2021 - 09/2012
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2019
2	Carcinoma (Carcinomatosis) 02/2019 - 09/2012
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2013
1	Leukemia 09/2012
1	Scrapie 03/2011
1	Neuroblastoma 03/2011
1	Iron Overload 04/2008

Drug/Important Bio-Agent (IBA)

5	Cisplatin (Platino)FDA LinkGeneric 02/2019 - 10/2013
4	CopperIBA 12/2021 - 04/2008
4	bis(1,10-phenanthroline)copper(2+) ionIBA 01/2020 - 09/2012
2	Glutathione (Reduced Glutathione)IBA 02/2019 - 09/2012
2	MetalsIBA 10/2015 - 04/2008
1	EnzymesIBA 12/2021
1	salubrinalIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 02/2019
1	LipidsIBA 01/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019
1	LigandsIBA 01/2019
1	EthylenethioureaIBA 01/2019
1	PhenanthrolinesIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2017
1	ImidazolidinesIBA 10/2013
1	ThionesIBA 10/2013
1	Antineoplastic Agents (Antineoplastics)IBA 09/2012
1	Prion ProteinsIBA 03/2011
1	IronIBA 04/2008
1	DeferiproneIBA 04/2008

Therapy/Procedure

3	Therapeutics 01/2019 - 04/2008